What we know and mostly do not know about bronchiolitis obliterans syndrome
Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike
Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
Prognostic value of CD34 + peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation
Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients
Outcome of children requiring intensive care following haematopoietic SCT for primary immunodeficiency and other non-malignant disorders
Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study
CsA 2-h concentration correlates best with area under the concentrationtime curve after allo-SCT compared with trough CsA
Prognostic impact of iron parameters in patients undergoing allo-SCT
Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas
G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT
Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma
The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study
Secondary solid tumors after allogeneic hematopoietic SCT in Japan
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT
Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia
Tear physiology in dry eye associated with chronic GVHD
The role of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis
Prognostic value of response after upfront therapy for acute GVHD
A case of membranous nephropathy associated with chronic GVHD successfully treated with rituximab
Intensive chemotherapy for a relapsed ALL patient who received living-donor lobar lung transplantation
Molecular remission of FLT3-ITD+ positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib
Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD
Encouraging results of preserving ovarian function after allo-HSCT with RIC
Circulating CD34+ cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT
Impact of response to thalidomide-, lenalidomide- or bortezomibcontaining induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation
Oral cavity care in patients after high-dose chemotherapy and stem cell transplantation: The East Forum EBMT Nurses Group standard of care
Serum (1→3)-β-D-glucan levels (Fungitell assay) is not useful as a screening test for recipients of an allogeneic HSCT while on immunoglobulin replacement
Severe pruritus and hypothermia as the primary manifestations of Human Herpes Virus-6 encephalitis after pediatric cord blood transplantation
Carcinomatosis lymphangitis and pleurisy after allo-SCT in two patients with secondary leukemia after breast cancer
Allogeneic hematopoietic stem cell collection from a donor with end-stage renal disease
Successful allo-HSCT with a minimal myeloablative conditioning regimen in an adult patient with Fanconi's anemia